Liposome- or LDL-administered Zn (II)-phthalocyanine as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency
1990

Using Zn-phthalocyanine for Tumor Treatment

Sample size: 30 publication Evidence: moderate

Author Information

Author(s): E. Reddi, C. Zhou, R. Biolo, E. Menegaldo, G. Jori

Primary Institution: Department of Biology, University of Padova; Cancer Institute, Chinese Academy of Medical Science

Hypothesis

Can Zn-phthalocyanine administered via liposomes or LDL effectively target tumors and enhance photodynamic therapy?

Conclusion

Zn-phthalocyanine is an effective photodynamic agent for tumor treatment, showing selective localization and slow clearance from tumors.

Supporting Evidence

  • Zn-Pc doses as low as 0.07-0.35 mg/kg can induce significant tumor necrosis.
  • LDL administration resulted in higher Zn-Pc uptake by tumors compared to liposomes.
  • Photodynamic therapy showed effective tumor necrosis even at long intervals after drug administration.

Takeaway

This study shows that a special drug called Zn-phthalocyanine can help treat tumors when used with light, and it stays in the tumor for a long time.

Methodology

Mice with tumors were treated with Zn-phthalocyanine delivered via liposomes or LDL, followed by photodynamic therapy using red light.

Limitations

The study may not fully represent human responses due to the use of animal models.

Participant Demographics

Female Balb/c mice, 18-20g body weight.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication